The authors report on three chronic, treatment refractory schizophrenic patients who dramatically improved when placed on very high doses of loxapine (300-500 mg/day). Numbness transiently appeared in two patients at very high doses of loxapine; it may be a frequently occurring but unreported side effect. The relative lack of serious side effects to very high dose loxapine suggests that this may be a useful intervention in carefully selected refractory patients. The authors recommended that controlled studies be done to elucidate the benefit to risk ratio.
ASJC Scopus subject areas
- Psychiatry and Mental health